609 related articles for article (PubMed ID: 33928831)
1. Drug delivery of amoxicillin molecule as a suggested treatment for covid-19 implementing functionalized mesoporous SBA-15 with aminopropyl groups.
Alazzawi HF; Salih IK; Albayati TM
Drug Deliv; 2021 Dec; 28(1):856-864. PubMed ID: 33928831
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and characterization of a modified surface of SBA-15 mesoporous silica for a chloramphenicol drug delivery system.
Albayati TM; Salih IK; Alazzawi HF
Heliyon; 2019 Oct; 5(10):e02539. PubMed ID: 31667391
[TBL] [Abstract][Full Text] [Related]
3. Ketoprofen mesoporous silica nanoparticles SBA-15 hard gelatin capsules: preparation and in vitro/in vivo characterization.
Abd-Elrahman AA; El Nabarawi MA; Hassan DH; Taha AA
Drug Deliv; 2016 Nov; 23(9):3387-3398. PubMed ID: 27167529
[TBL] [Abstract][Full Text] [Related]
4. Optimization of tetracycline hydrochloride adsorption on amino modified SBA-15 using response surface methodology.
Hashemikia S; Hemmatinejad N; Ahmadi E; Montazer M
J Colloid Interface Sci; 2015 Apr; 443():105-14. PubMed ID: 25540827
[TBL] [Abstract][Full Text] [Related]
5. Luminescence functionalization of SBA-15 by YVO4:Eu3+ as a novel drug delivery system.
Yang P; Huang S; Kong D; Lin J; Fu H
Inorg Chem; 2007 Apr; 46(8):3203-11. PubMed ID: 17371013
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, amino-functionalization of mesoporous silica and its adsorption of Cr(VI).
Li J; Miao X; Hao Y; Zhao J; Sun X; Wang L
J Colloid Interface Sci; 2008 Feb; 318(2):309-14. PubMed ID: 18036539
[TBL] [Abstract][Full Text] [Related]
7. Adsorption and release of ampicillin antibiotic from ordered mesoporous silica.
Nairi V; Medda L; Monduzzi M; Salis A
J Colloid Interface Sci; 2017 Jul; 497():217-225. PubMed ID: 28285049
[TBL] [Abstract][Full Text] [Related]
8. Preparation and evaluation of aminopropyl-functionalized manganese-loaded SBA-15 for copper removal from aqueous solution.
Lei D; Zheng Q; Wang Y; Wang H
J Environ Sci (China); 2015 Feb; 28():118-27. PubMed ID: 25662246
[TBL] [Abstract][Full Text] [Related]
9. Preparation, characterization and application of p-tert-butyl-calix[4]arene-SBA-15 mesoporous silica molecular sieves.
Huang H; Zhao C; Ji Y; Nie R; Zhou P; Zhang H
J Hazard Mater; 2010 Jun; 178(1-3):680-5. PubMed ID: 20185235
[TBL] [Abstract][Full Text] [Related]
10. [Structure and adsorption characterization of SBA-16 and functionalized materials].
Zheng Z; Guo G; Hu Y; Feng F; Xu G; Tan H
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2011 Aug; 28(4):768-73. PubMed ID: 21936378
[TBL] [Abstract][Full Text] [Related]
11. Functionalized SBA-15 materials as carriers for controlled drug delivery: influence of surface properties on matrix-drug interactions.
Song SW; Hidajat K; Kawi S
Langmuir; 2005 Oct; 21(21):9568-75. PubMed ID: 16207037
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and characterization of mesoporous silica and its application as drug delivery system for glimepiride.
Muhana F; Al-Ani I; Al-Akayleh F; Marzouqa D; Khalili F; Al-Khatib H; Mutti H; Shalan N
Pharmazie; 2021 Jul; 76(7):300-307. PubMed ID: 34256891
[TBL] [Abstract][Full Text] [Related]
13. Preparation of efficient quercetin delivery system on Zn-modified mesoporous SBA-15 silica carrier.
Trendafilova I; Szegedi A; Mihály J; Momekov G; Lihareva N; Popova M
Mater Sci Eng C Mater Biol Appl; 2017 Apr; 73():285-292. PubMed ID: 28183610
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and surface modification of mesoporous silica nanoparticles and its application as carriers for sustained drug delivery.
Ahmadi E; Dehghannejad N; Hashemikia S; Ghasemnejad M; Tabebordbar H
Drug Deliv; 2014 May; 21(3):164-72. PubMed ID: 24116869
[TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of tungsten carbide confined in the channels of SBA-15 mesoporous silica.
Hu L; Ji S; Xiao T; Guo C; Wu P; Nie P
J Phys Chem B; 2007 Apr; 111(14):3599-608. PubMed ID: 17388515
[TBL] [Abstract][Full Text] [Related]
16. Modified SBA-15 mesoporous silica for heavy metal ions remediation.
Mureseanu M; Reiss A; Stefanescu I; David E; Parvulescu V; Renard G; Hulea V
Chemosphere; 2008 Nov; 73(9):1499-504. PubMed ID: 18760443
[TBL] [Abstract][Full Text] [Related]
17. Organically modified MCM-type material preparation and its usage in controlled amoxicillin delivery.
Li Z; Su K; Cheng B; Deng Y
J Colloid Interface Sci; 2010 Feb; 342(2):607-13. PubMed ID: 19948346
[TBL] [Abstract][Full Text] [Related]
18. Controlled drug delivery system based on ordered mesoporous silica matrices of captopril as angiotensin-converting enzyme inhibitor drug.
Popovici RF; Seftel EM; Mihai GD; Popovici E; Voicu VA
J Pharm Sci; 2011 Feb; 100(2):704-14. PubMed ID: 20740675
[TBL] [Abstract][Full Text] [Related]
19. Nanostructured SBA-15 host applied in ketorolac tromethamine release system.
Cussa J; Juárez JM; Gómez Costa MB; Anunziata OA
J Mater Sci Mater Med; 2017 Aug; 28(8):113. PubMed ID: 28625001
[TBL] [Abstract][Full Text] [Related]
20. Adsorption of lysozyme on hyaluronic acid functionalized SBA-15 mesoporous silica: a possible bioadhesive depot system.
Medda L; Casula MF; Monduzzi M; Salis A
Langmuir; 2014 Nov; 30(43):12996-3004. PubMed ID: 25295387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
